About Us

Medexus Pharmaceuticals Inc. is a North American focused, specialty pharmaceutical business that operates through three segments:  


  • Medac Pharma USA a fully integrated commercial infrastructure focused on auto-immune diseases in the USA
  • Medexus Pharma Canada a fully integrated commercial infrastructure focused on auto-immune disease and pediatric diseases in Canada
  • A Business Development function, which works to keep our product pipeline full

OUR UNIQUENESS


SOLVING UNMET NEEDS IN THE HEALTHCARE ENVIRONMENT BRINGING SAFE, EFFECTIVE UNIQUE PRODUCTS TO THE MARKET PROVIDING A BETTER QUALITY OF LIFE.

PHILOSOPHY / VALUES


Innovation as a driving force Medexus continuously licenses or acquires new products and solutions aimed at addressing the essential needs of consumers, patients and health care partners.

VALUE IN PEOPLE & PRODUCTS


Focusing on trust and transparency within our organization, as well as with our customers and partners. We commit to maintaining the highest level of product quality on the market.

VISION


Our vision is to provide the best healthcare products to Consumers and Healthcare Professionals, through our core values of Quality, Customer Service, Innovation and Teamwork.

MANAGEMENT TEAM

Ken d’Entremont – Chief Executive Officer and Director

  • Founder, President & CEO of Medexus Inc.
  • Previously General Manager and VP, Business Development of Sanofi, where he led the in-licensing initiatives for Sanofi Canada
  • Holds a BSc (Chemistry) from McMaster University

Roland Boivin – Chief Financial Officer

  • Appointed CFO of Pediapharm on July 1, 2013
  • Held several management positions at 3M Canada, was a member of the company’s Executive Leadership Team and had overall responsibility of the Consumer Division
  • Holds a BCom from McGill, a MBA from Queen’s and is a Certified Six Sigma Black Belt

Terri Shoemaker – President, Medac Pharma USA

  • President and CEO of Medac Pharma since debut in 2012
  • Previously VP Sales at InterMune, co-founder of BioPharm SS and held various other roles at Pharmion, Celgene and Dupont Pharmaceuticals
  • Holds a BS (Comm. Science) from Missouri State and M.S. (Comm. Science and Disorders) from U of Central Missouri

Sylvain Chrétien – President, Canadian Operation and Director

  • Founder, President and CEO of Pediapharm since 2008
  • Over 29 years of experience in both the pharmaceutical and the biotechnology sectors from holding key employment positions at Nordic Laboratories, Pfizer Canada and Biorthex Inc.
  • Holds a B Sc in Kinesiology (Laval University) and Executive MBA specialized in biotechnology (UQAM)

BOARD OF DIRECTORS

Peter van der Velden – Chairman

  • Currently Managing General Partner of Lumira Capital, Canada’s largest dedicated life sciences venture capital investor
  • Previous experience in banking, venture capital and private equity investing

Benoit Gravel

  • Has 30 years experience in the pharmaceutical industry from his work experience at Rhône-Poulenc, Aventis and Sanofi
  • Began his career as an economist in the Energy and Transportation industries
  • Former Chairman of Public Sector Pension Investment Board and former Chair of its Compensation Committee
  • Held senior positions at TD Bank Financial Group
  • Former director of TM BioScience Inc, MDS Capital Corporation and other notable funds and ventures

Michael Mueller

  • Former Chairman of Public Sector Pension Investment Board and former Chair of its Compensation Committee
  • Held senior positions at TD Bank Financial Group
  • Former director of TMBioScience Inc, MDS Capital Corporation and other notable funds and ventures

Stephen Nelson

  • Senior Vice-President Portfolio Manager and Investment Advisor with TD Wealth
  • Private Investment Advice
  • Mr. Nelson currently manages over $2 billion in investment assets and has been a member of TD Waterhouse’s President Club for the past 16 consecutive years
  • Has served as a director for a number of private companies

Sylvain Chrétien – President, Canadian Operation and Director

  • Founder, President and CEO of Pediapharm since 2008
  • Over 29 years of experience in both the pharmaceutical and the biotechnology sectors from holding key employment positions at Nordic Laboratories, Pfizer Canada and Biorthex Inc.
  • Holds a B Sc in Kinesiology (Laval University) and Executive MBA specialized in biotechnology (UQAM)

Ken d’Entremont – Chief Executive Officer and Director

  • Founder, President & CEO of Medexus Inc.
  • Previously General Manager and VP, Business Development of Sanofi, where he led the in-licensing initiatives for Sanofi Canada
  • Holds a BSc (Chemistry) from McMaster University